What is Titan Bio-Tech Ltd (524717) share price return in the past 10 years?

Titan Bio-Tech Ltd share price has appreciated 52.3% annually (CAGR) over the past ten years.

What is the share price of Titan Bio-Tech Ltd (524717)?

Company share prices are keep on changing according to the market conditions. The current trading price of Titan Bio-Tech Ltd (524717) on 04-Jun-2026 16:59:59 at 16:59 is 442.25.

What is the P/E ratio of Titan Bio-Tech?

The latest standalone P/E ratio of Titan Bio-Tech as of 04-Jun-2026 is 66.58.

What is the P/B ratio of Titan Bio-Tech Ltd (524717)?

The latest standalone P/B ratio of Titan Bio-Tech Ltd (524717) as of 04-Jun-2026 is 10.70.

What is the 52-week high and low of Titan Bio-Tech Ltd (524717)?

The 52-week high of Titan Bio-Tech Ltd (524717) is Rs. 555.65 and the 52-week low is Rs. 74.73.

Titan Bio-Tech Ltd (524717) Share Analysis – Quality, Valuation Zone & Price Trend & DeciZen Rating

Name: Titan Bio-Tech Ltd (524717)
Brand: Titan Bio-Tech

Key Metrics

Valuation Multiples

Market Cap

₹1,827 Cr.

Current Price

₹442.3

52-Week Low / High

₹75 / 556

TTM EPS

₹6.6

TTM Sales

₹206 Cr.

Book Value per Share

₹41.4

P/E Ratio

66.58

Higher than its 5-year historical median

Industry PE

50.2

Price to Book (P/B)

10.70

Higher than its 5-year historical median

Price to Sales (P/S)

8.86

Higher than its 5-year historical median

EV/EBITDA

41.56

Higher than its 5-year historical median

Dividend Yield

0.47%

Profitability Efficiency

Return on Equity (ROE)

13.36%

Outperforms industry median

Return on Capital Employed (ROCE)

17.80%

Outperforms industry median

Return on Assets (ROA)

11.00%

Operating Profit Margin

16.3%

Net Profit Margin

11.68%

Gross Profit Margin

18.2%

Growth Momentum
1-yr vs 3-yr growth

Sales Growth (1 Year)

Slowing versus 3-year growth rate

-4.64%

Operating Profit Growth (1 Year)

Slowing versus 3-year growth rate

-25.82%

Net Profit Growth (1 Year)

Slowing versus 3-year growth rate

-22.78%

Asset Quality

Promoter Holding

55.78%

Pledged shares (%) of Promoter's holding (%)

0.00%

Reserves

₹163 Cr.

Equity

₹8.3 Cr.

Face Value

₹2

All Time Low / High

₹0.21 / 555.65

Titan Bio-Tech stock performance

Key Ratios

Check Before You Invest

Quality

Very Good

Check detailed performance

Valuation

Overvalued

Check Valuation charts

Price Trend

Weak

Check Price chart

Q.1 Is Titan Bio-Tech Ltd a good quality company?

Titan Bio-Tech Ltd is a good quality company, based on a consistently good multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

We have analysed the performance of the company on the following:

How has it performed on generating Profits?
By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.
How efficiently has it utilized Capital?
By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.
How is it managing its Debt?
By checking its Debt to Equity and Cash Flow from Operations.

How does Titan Bio-Tech Ltd performance compare with that of its Peers?

Q.1 Revenue growth of Titan Bio-Tech Ltd vs industry peers?

Titan Bio-Tech Ltd revenue CAGR is 17.63%, compared to the industry median CAGR of 7.53%, indicating faster growth and gaining its market share.

Q.1 Promoter shareholding and pledge status of Titan Bio-Tech Ltd?

Promoters hold 55.78% of the Titan Bio-Tech Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Q.1 Stock return of Titan Bio-Tech Ltd over the last decade?

Over the last 9 year(s), the stock has delivered a CAGR of 52% based on the current price.

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
ROCE % ⓘ	12%	12.7%	12.9%	12.5%	18.6%	61.6%	35.5%	27.9%	26.3%	17.8%	-
Value Creation Index ⓘ	-0.2	-0.1	-0.1	-0.1	0.3	3.4	1.5	1.0	0.9	0.3	-
Growth Parameters ⓘ
Sales ⓘ	45.6	52.5	55.5	58.2	69.5	122	124	144	164	156	206
Sales YoY Gr.	-	15%	5.9%	4.9%	19.3%	76.3%	0.9%	16.6%	13.9%	-4.6%	-
Adj EPS ⓘ	0.5	0.6	0.6	0.7	1.3	6.9	5.3	5.1	5.6	4.3	6.6
YoY Gr.	-	31.1%	-6.8%	18.2%	106.2%	417.2%	-24.2%	-3.2%	10.8%	-23.1%	-
BVPS (₹) ⓘ	5.6	6	6.3	7.7	9.2	15.9	20.9	25.7	31.1	35.1	41.4
Adj Net Profit ⓘ	1.7	2.3	2.1	2.7	5.5	28.6	21.7	21	23.3	17.9	27
Cash Flow from Ops. ⓘ	4.9	-0	1.6	6.2	6.9	17.6	22	21.2	21.2	20.1	-
Debt/CF from Ops. ⓘ	2.3	-579.6	16.3	3.5	2.6	0.5	0.3	0.3	0.3	0.1	-

CAGR ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	14.7%	17.6%	8.2%	-4.6%
Adj EPS ⓘ	28.6%	26.4%	-6.2%	-23.1%
BVPSⓘ	22.7%	30.9%	19%	13%
Share Price	52.3%	48.6%	102%	431.9%

Key Financial Parameters ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
Return on Equity % ⓘ	8.2	10.2	9	9.7	16	55.3	28.5	21.8	19.8	13.1	17.4
Op. Profit Mgn % ⓘ	8.8	10.5	11.9	12.9	15.7	34.2	25.3	20.5	20.9	16.3	18.7
Net Profit Mgn % ⓘ	3.8	4.3	3.8	4.6	8	23.4	17.6	14.6	14.2	11.4	13.3
Debt to Equity ⓘ	0.5	1	1	0.7	0.5	0.1	0.1	0.1	0.1	0	0
Working Cap Days ⓘ	155	147	175	192	185	150	189	175	168	189	76
Cash Conv. Cycle ⓘ	114	111	140	156	147	102	125	122	122	144	51

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Sales	46	52	56	58	69	122	124	144	164	156
Operating Expenses ⓘ +	42	47	49	51	59	81	92	114	130	131
Manufacturing Costs	5	7	7	7	8	15	13	17	19	18
Material Costs	30	33	31	31	36	49	58	70	76	73
Employee Cost	3	3	6	8	9	11	14	18	24	26
Other Costs ⓘ	4	4	5	5	5	6	7	10	11	14
Operating Profit ⓘ	4	6	7	7	11	42	31	30	34	25
Operating Profit Margin (%)	8.7%	10.5%	11.9%	12.8%	15.7%	34.2%	25.3%	20.5%	20.9%	16.3%
Other Income ⓘ +	0	0	0	1	0	1	1	2	2	4
Exceptional Items ⓘ	0	0	0	0	1	-0	0	0	0	0
Interest ⓘ	1	1	2	2	2	1	1	1	1	1
Depreciation ⓘ	1	1	1	2	2	2	2	3	3	4
Profit Before Tax ⓘ	3	3	4	4	8	39	29	28	32	24
Tax ⓘ	1	1	1	1	2	10	7	7	8	6
Profit After Tax	2	2	2	3	6	29	22	21	24	18
PAT Margin (%)	3.8%	4.5%	4.3%	5.3%	8.9%	23.5%	17.6%	14.6%	14.4%	11.7%
Adjusted EPS (₹)	0.5	0.6	0.6	0.8	1.5	7.0	5.3	5.1	5.7	4.4
Dividend Payout Ratio (%)	33.70%	24.80%	24.20%	0%	13.30%	4.30%	5.70%	7.10%	7%	9.10%

Valuation of Titan Bio-Tech - Standalone

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Equity and Liabilities
Shareholders Fund +	21	23	24	32	38	66	86	106	128	145
Share Capital ⓘ	8	8	8	8	8	8	8	8	8	8
Reserves ⓘ	14	15	17	23	30	58	78	98	120	137
Debt +	11	22	25	21	17	8	6	6	7	2
Long Term Debt	4	15	17	12	8	2	1	0	0	0
Short Term Debt	7	7	7	9	8	6	5	6	6	2
Minority Interest	0	0	0	0	0	0	0	0	0	0
Trade Payables	2	1	1	2	4	3	4	6	3	5
Others Liabilities ⓘ	4	4	6	6	8	20	19	20	21	20
Total Liabilities ⓘ	39	50	56	61	67	96	115	138	160	172
Fixed Assets
Net Fixed Assets ⓘ +	10	11	11	26	25	27	35	36	52	57
Gross Block	17	18	19	34	35	39	49	52	71	81
Accumulated Depreciation	6	7	8	8	10	12	14	17	19	23
CWIP ⓘ	5	9	13	0	0	0	4	13	3	2
Investments ⓘ	1	1	1	1	1	1	4	12	23	24
Inventories	11	14	17	20	24	27	35	36	46	51
Trade Receivables	6	6	8	8	11	16	16	21	19	19
Cash Equivalents	3	4	1	2	2	5	7	5	3	6
Others Assets ⓘ	4	4	4	4	4	19	15	15	15	14
Total Assets ⓘ	39	50	56	61	67	96	115	138	160	172

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Cash Flow From Operating Activity ⓘ +	5	-0	2	6	7	18	22	21	21	20
PBT ⓘ	3	3	4	4	8	39	29	28	32	24
Adjustment ⓘ	2	2	3	4	4	4	4	4	5	5
Changes in Working Capital ⓘ	1	-5	-5	-1	-4	-15	-3	-3	-7	-4
Tax Paid ⓘ	-1	-1	-1	-1	-2	-10	-7	-7	-8	-6
Cash Flow From Investing Activity ⓘ +	-5	-7	-5	-4	-1	-4	-16	-21	-20	-10
Capex	-4	-0	-5	-4	-1	-4	-14	-4	-19	-9
Net Investments	-1	-6	-0	0	0	0	-3	-8	-12	-1
Others ⓘ	-0	-0	0	0	0	0	0	-10	11	1
Cash Flow From Financing Activity ⓘ +	2	8	0	-2	-6	-10	-4	-2	-3	-8
Net Proceeds from Shares ⓘ	0	0	0	4	0	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	4	11	3	-5	-4	-7	-1	-1	0	-0
Interest Paid ⓘ	-1	-1	-2	-2	-2	-1	-1	-1	-1	-1
Dividend Paid ⓘ	-1	-1	-1	0	0	-1	-1	-1	-1	-2
Others ⓘ	-0	-0	0	2	-0	-1	-1	0	-0	-5
Net Cash Flow ⓘ	2	2	-3	1	0	4	2	-2	-2	2

Financial Ratio

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Ratios
ROE (%)	8.21	10.47	10.13	11.01	17.85	55.53	28.52	21.86	20.18	13.36
ROCE (%)	11.95	12.71	12.92	12.5	18.63	61.63	35.48	27.9	26.3	17.8
Asset Turnover Ratio	1.35	1.25	1.06	1	1.09	1.51	1.17	1.14	1.1	0.94
PAT to CFO Conversion(x)	2.5	-0	1	2	1.17	0.62	1	1	0.88	1.11
Working Capital Days
Receivable Days	45.50	39.20	46.40	49.70	48.30	39.70	48	47.40	44.10	43.70
Inventory Days	82.40	82.50	102.30	116.40	115.80	76	90.90	89.80	90.90	112.30
Payable Days	19.30	16.20	13.20	18.60	28.50	23.50	21.70	25.40	21.50	21.60

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Titan Bio-Tech Ltd FAQs

The current trading price of Titan Bio-Tech on 04-Jun-2026 16:59 is ₹442.2.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 03-Jun-2026 the market cap of Titan Bio-Tech stood at ₹1,827.3 Cr

The latest P/E ratio of Titan Bio-Tech as of 03-Jun-2026 is 66.58.

The latest P/B ratio of Titan Bio-Tech as of 03-Jun-2026 is 10.70.

The 52-week high of Titan Bio-Tech is ₹555.6 and the 52-week low is ₹74.73.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Titan Bio-Tech is ₹206 ( Cr.) .

Past 10 year's financial track record analysis by Moneyworks4me indicates that Titan Bio-Tech Ltd is a good quality company.

The key valuation ratios of Titan Bio-Tech Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Titan Bio-Tech Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

About Titan Bio-Tech Ltd

Titan Biotech was established in 1992 with an objective of serving the scientific community and mankind by way of providing good quality of biological products i.e. protein hydrolysis, peptones and their derivatives, extracts, dehydrated microbiological culture media, plant tissue culture media and laboratory chemicals.

All the biological products are basically conducive to the growth of microorganisms and their primary use is in the development and growth of microorganisms in clinical diagnosis, production of vaccines, antibiotics and antisera, antimicrobial susceptibility testing to antibiotics, checking the bacterial contamination in food & water samples in departments of microbiology and relevant fields of science in medical colleges/universities/industries and tissue culture laboratories.

The company has developed more than 1700 Dehydrated Culture Media, Media Bases, and special type of Peptones and Hydrolysates for vaccine production and other uses. Titan uses the basic raw material i.e. Meet, Bile, Liver Blood, Brain, Heart and other parts of the animals in its process procured from the slaughter houses and other vegetable products like soya and casein, etc. converting them into free flowing powder to produce peptones, extracts and hydrolysates which are further used in manufacturing of dehydrated culture media and as raw material in pharmaceutical, health products and other Industries.

Recently it has introduced a wide range of chromomeric / fluorogenic culture media that does not require any further identification tests. This time they are introducing a range of vegetable culture media, which are animal free and possess equivalent growth characteristics to the Culture media that use animal peptones.

Besides these biological products, it also has a range of laboratory chemicals, analytical reagents, stains and indicators and Readymade stain kits. These materials are used in laboratories to carry out various tests and research work.

The company also manufactures wide range of plant growth promotor and its various basic ingredients, hormones, minerals and vitamins premixes as well as amino acid in liquid, powder and granular forms. Itd product Aminofert has become very popular among the users. The basic raw materials of this product are mixtures of amino acids, minerals and vitamins. It gives complete nourishment and helps in growth and productivity.

Product range of the company includes:

Culture Media & Supplements

Biological Media Bases + TBL Agroses
Redymade Liquid Media In Sterile Glass Bottle
Readymade Sterile Liqiud Media in Glass Bottle
Media Supplements
Dehydrated Culture Media
Sterile Media (Gamma Radiations)

Plant Tissue Culture

Plant Tissue Culture Media
Plant Growth Improver

Lab Chemicals & Reagents

Stains and Indicators Solutions
Readymade Stains Kit
Readymade Analytical Reagents
Laboratory Chemicals & Reagents
Laboratory Disposables
Lab Chemicals in Bulk

Bulk Products

Pharma and Healthcare Products
Agro Products
Animal Feed Products
Amino Acids in Bulk Packs

Achievements/ recognition:

ISO 9001:2000 certified company

Titan Bio-Tech Ltd (524717)

Titan Bio-Tech Ltd (524717)

Titan Bio-Tech stock performance

Check Before You Invest

Quality

Valuation

Price Trend

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Profit And Loss

Valuation of Titan Bio-Tech - Standalone

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Analyst's Notes

Balance Sheet

Equity and Liabilities

Fixed Assets

Cash Flow

Financial Ratio

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Titan Bio-Tech Ltd FAQs

About Titan Bio-Tech Ltd

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Titan Bio-Tech Ltd (524717)

Titan Bio-Tech Ltd (524717)

Titan Bio-Tech stock performance

Check Before You Invest

Quality

Valuation

Price Trend

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Profit And Loss

Valuation of Titan Bio-Tech - Standalone

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

Balance Sheet

Equity and Liabilities

Fixed Assets

Cash Flow

Financial Ratio

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Titan Bio-Tech Ltd FAQs

What is the share price of Titan Bio-Tech?

What is the market cap of Titan Bio-Tech?

What is the P/E ratio of Titan Bio-Tech?

What is the P/B ratio of Titan Bio-Tech?

What is the 52-week high and low of Titan Bio-Tech?

What is the TTM revenue of Titan Bio-Tech?

Is Titan Bio-Tech Ltd a good quality company?

Is Titan Bio-Tech Ltd undervalued or overvalued?

Is Titan Bio-Tech Ltd a good buy now?

About Titan Bio-Tech Ltd

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.